Cargando…
A screen for protective drugs against delayed hypoxic injury
Despite longstanding efforts to develop cytoprotective drugs against ischemia/reperfusion (IR) injuries, there remains no effective therapeutics to treat hypoxic injury. The failure of traditional strategies at solving this problem suggests the need for novel and unbiased approaches that can lead to...
Autores principales: | Sun, Chun-Ling, Zhang, Huiliang, Liu, Meng, Wang, Wang, Crowder, C. Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398677/ https://www.ncbi.nlm.nih.gov/pubmed/28426808 http://dx.doi.org/10.1371/journal.pone.0176061 |
Ejemplares similares
-
Effect of the mitochondrial unfolded protein response on hypoxic death and mitochondrial protein aggregation
por: Yan, Junyi, et al.
Publicado: (2021) -
A Pharmacodynamic Evaluation of the Protective Effects of Roxadustat Against Hypoxic Injury at High Altitude
por: Guo, Qianwen, et al.
Publicado: (2023) -
Protective effect and mechanism of procyanidin B2 against hypoxic injury of cardiomyocytes
por: Xue, Zhimin, et al.
Publicado: (2023) -
Hypoxic preconditioning reduces NLRP3 inflammasome expression and protects against cerebral ischemia/reperfusion injury
por: Pang, Yi-Qiang, et al.
Publicado: (2021) -
Sirtuin 1 Mediates Protection Against Delayed Cerebral Ischemia in Subarachnoid Hemorrhage in Response to Hypoxic Postconditioning
por: Diwan, Deepti, et al.
Publicado: (2021)